Connection
Thomas Campbell to Doxorubicin
This is a "connection" page, showing publications Thomas Campbell has written about Doxorubicin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.363 |
|
|
|
-
Mazhindu T, Nyangwara VA, Borok MZ, Masimirembwa C, Flaig T, Campbell TB, Ndlovu N. Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe. S Afr Med J. 2026 Jun 02; 116(5):e3655.
Score: 0.203
-
Nyangwara VA, Mazhindu T, Chikwambi Z, Masimirembwa C, Campbell TB, Borok M, Ndlovu N. Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients. Br J Clin Pharmacol. 2024 Aug; 90(8):1782-1789.
Score: 0.161